13FPulse
MR

MRNA MODERNA INC

2026Q2 · CUSIP 60770K107 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
758
Institutions that reported holding it to the SEC
Net increase in holders
+38
Last quarter 720 → now 758
How unusual is that
Top 10%
Stronger buying than 92% of US stocks
What the filings say, in one paragraph

758 funds held MRNA at the end of 2026Q2, up 38 from the quarter before. That is stronger buying than 92.3% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $2.2B(YoY -27.6%), return on equity is -46.6%. MRNA has had 16 buying rushes in its history, and the price moved +20.7% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q1: holders=103 2019Q2: holders=135 2019Q3: holders=132 2019Q4: holders=158 2020Q1: holders=291 2020Q2: holders=477 2020Q3: holders=537 2020Q4: holders=708 2021Q1: holders=766 2021Q2: holders=885 2021Q3: holders=1125 2021Q4: holders=1096 2022Q1: holders=994 2022Q2: holders=969 2022Q3: holders=904 2022Q4: holders=1061 2023Q1: holders=1007 2023Q2: holders=957 2023Q3: holders=878 2023Q4: holders=875 2024Q1: holders=897 2024Q2: holders=951 2024Q3: holders=784 2024Q4: holders=744 2025Q1: holders=690 2025Q2: holders=670 2025Q3: holders=642 2025Q4: holders=674 2026Q1: holders=720 2026Q2: holders=758 -240 -120 +0 +120 +240 926371182 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 16 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 10%
2026Q1 Top 10% +65.8%
2025Q4 Top 20% +0.8% -3.2%
2024Q2 Top 5% -27.3% -54.2%
2024Q1 Top 20% -12.8% -32.3%
2022Q4 Top 1% in the market -7.4% -27.3%
2021Q3 Top 1% in the market -3.0% -39.6%
2021Q2 Top 1% in the market -14.5% -41.3%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
265
Change in large funds
+24
Total value they hold
$22.2B
Funds buying for the first time
145
Funds that sold out entirely
107
Price change that quarter
+220.7%
Funds holding puts (bearish)
38
Funds holding calls (bullish)
38

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-7.98
EPS YoY
Revenue (TTM)
$2.2B
Revenue YoY
-27.6%
Net margin
-141.4%
ROE
-46.6%
Debt ratio
38.3%
FCF (TTM)
-$1.2B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 7.70 2021-12-31: EPS 11.29 2022-03-31: EPS 8.58 2022-06-30: EPS 5.24 2022-09-30: EPS 2.53 2022-12-31: EPS 3.77 2023-03-31: EPS 0.19 2023-06-30: EPS -3.62 2023-09-30: EPS -9.53 2023-12-31: EPS 0.63 2024-03-31: EPS -3.07 2024-06-30: EPS -3.33 2024-09-30: EPS 0.03 2024-12-31: EPS -2.91 2025-03-31: EPS -2.52 2025-06-30: EPS -2.13 2025-09-30: EPS -0.51 2025-12-31: EPS -2.10 2026-03-31: EPS -3.40 2026-06-30: EPS -1.97 0B 2.2B 4.4B $B -10.48 0.97 12.42 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 20 36 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-1.7B1.1B4.0B 201820192020202120222023202420252026
Latest quarter $-692M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.